Skip to content

OncoHost vs Solid IO

OncoHost logo

OncoHost

A technology company transforming the approach to precision medicine for improved patient outcomes

53 employees · est. 2017 · Binyamina, Israel

VS
Solid IO logo

Solid IO

ENDING THE GUESSWORK IN CANCER CARE | Patient-specific organ-on-chip technology for precision oncology & immunotherapy

8 employees · est. 2025 · Helsinki, Finland

OncoHost is the older company (2017 vs 2025); OncoHost is the larger of the two.

Side-by-Side Comparison

OncoHost Solid IO
Founded
2017 older 2025
Headquarters
Binyamina, Israel Helsinki, Finland
Employees
53 larger 8
Industry
Biopharma, Biotechnology, Health Care Not tracked yet
Funding Stage
Series C Seed
Total Funding
$52.56M $800.00K
Funding Rounds
4 1
Services
Not tracked yet Tumor-on-chip platform, Patient-specific treatment insights, Immunotherapy research support, Early-stage clinical trial facilitation
Target Customers
Not tracked yet Pharmaceutical Companies, Biotech Firms, Cancer Clinics, Oncologists, Researchers
Taxonomy
Precision MedicineTechnology CompanyPROphet® PlatformProteomic Pattern AnalysisNon-small Cell Lung Cancer (NSCLC)Immunotherapy Decision-making +9 Organ-on-chip TechnologyPrecision OncologyImmunotherapyTumor MicroenvironmentClinical Trials OptimizationDrug Development Acceleration +8
Website
oncohost.com solid-io.com
OncoHost logo

About OncoHost

OncoHost is a technology company based in Israel that is revolutionizing the field of precision medicine to enhance patient outcomes. The company's flagship product, PROphet®, utilizes a plasma-based, proteomic pattern analysis to deliver personalized treatment insights for non-small cell lung cance...

Solid IO logo

About Solid IO

Solid IO, founded in 2025 and headquartered in Finland, is pioneering advancements in precision oncology and immunotherapy through its unique organ-on-chip technology. The company's slogan, "ENDING THE GUESSWORK IN CANCER CARE," underscores its commitment to providing patient-specific data that empo...

Also comparing in this category

Comparing more than these two?

Get OncoHost, Solid IO and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does OncoHost compare?

A PDF of OncoHost and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

OncoHost was founded in 2017, based in Binyamina, Israel, with 53 employees. OncoHost is a technology company based in Israel that is revolutionizing the field of precision medicine to enhance patient outcomes. The company's flagship product, PROphet®, utilizes a plasma-based,. Solid IO was founded in 2025, based in Helsinki, Finland, with 8 employees. Solid IO, founded in 2025 and headquartered in Finland, is pioneering advancements in precision oncology and immunotherapy through its unique organ-on-chip technology. The company's slogan, "ENDING TH.
OncoHost has raised $52.56M and Solid IO $800.00K. Latest stage: OncoHost Series C, Solid IO Seed.
Both list precision medicine among their focus areas.

Compare OncoHost with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at OncoHost on 12 Sep 2024, and Solid IO on 13 Nov 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout